Dual trajectories of physical activity and blood lipids in midlife women: The Study of Women's Health Across the Nation.
HDL cholesterol
LDL cholesterol
Midlife
Physical activity
Trajectory
Triglycerides
Journal
Maturitas
ISSN: 1873-4111
Titre abrégé: Maturitas
Pays: Ireland
ID NLM: 7807333
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
11
09
2020
revised:
09
11
2020
accepted:
02
02
2021
entrez:
16
3
2021
pubmed:
17
3
2021
medline:
4
5
2021
Statut:
ppublish
Résumé
Physical activity (PA) has the potential to attenuate cardiovascular disease risk in midlife women through multiple pathways, including improving lipid profiles. Longitudinal patterns of PA and blood lipid levels have not been studied in midlife women. Our study identified trajectories of PA and blood lipids across midlife and characterized the associations between these trajectories. We evaluated 2,789 participants from the Study of Women's Health Across the Nation (SWAN), a longitudinal cohort study with follow-up over the menopause transition. Women reported PA using the Kaiser Physical Activity Survey at seven study visits across 17 years of follow-up. Serum high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides were measured at eight study visits across the same 17-year follow-up period. We used group-based trajectory models to characterize trajectories of PA and blood lipids over midlife and dual trajectory models to determine the association between PA and blood lipid trajectories adjusted for race/ethnicity, body mass index category, smoking, and lipid-lowering medication use. Women were 46 years old, on average, at study entry. Forty-nine percent were non-Hispanic white; 32 % were Black; 10 % were Japanese; and 9 % were Chinese. We identified four PA trajectories, three HDL cholesterol trajectories, four LDL cholesterol trajectories, and two triglyceride trajectories. The most frequently occurring trajectories were the consistently low PA trajectory (69 % of women), the low HDL cholesterol trajectory (43 % of women), the consistently moderate LDL cholesterol trajectory (45 % of women), and the consistently low triglycerides trajectory (90 % of women). In dual trajectory analyses, no clear associations were observed between PA trajectories and HDL cholesterol, LDL cholesterol, or triglycerides trajectories. The most frequently observed trajectories across midlife were characterized by low physical activity, low HDL cholesterol, moderate LDL cholesterol, and low triglycerides. Despite the absence of an association between long-term trajectories of PA and blood lipids in this study, a large body of evidence has established the importance of clinical and public health messaging and interventions targeted at midlife women to promote regular and sustained PA during midlife to achieve other cardiovascular and metabolic benefits.
Sections du résumé
BACKGROUND
BACKGROUND
Physical activity (PA) has the potential to attenuate cardiovascular disease risk in midlife women through multiple pathways, including improving lipid profiles. Longitudinal patterns of PA and blood lipid levels have not been studied in midlife women. Our study identified trajectories of PA and blood lipids across midlife and characterized the associations between these trajectories.
METHODS
METHODS
We evaluated 2,789 participants from the Study of Women's Health Across the Nation (SWAN), a longitudinal cohort study with follow-up over the menopause transition. Women reported PA using the Kaiser Physical Activity Survey at seven study visits across 17 years of follow-up. Serum high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides were measured at eight study visits across the same 17-year follow-up period. We used group-based trajectory models to characterize trajectories of PA and blood lipids over midlife and dual trajectory models to determine the association between PA and blood lipid trajectories adjusted for race/ethnicity, body mass index category, smoking, and lipid-lowering medication use.
RESULTS
RESULTS
Women were 46 years old, on average, at study entry. Forty-nine percent were non-Hispanic white; 32 % were Black; 10 % were Japanese; and 9 % were Chinese. We identified four PA trajectories, three HDL cholesterol trajectories, four LDL cholesterol trajectories, and two triglyceride trajectories. The most frequently occurring trajectories were the consistently low PA trajectory (69 % of women), the low HDL cholesterol trajectory (43 % of women), the consistently moderate LDL cholesterol trajectory (45 % of women), and the consistently low triglycerides trajectory (90 % of women). In dual trajectory analyses, no clear associations were observed between PA trajectories and HDL cholesterol, LDL cholesterol, or triglycerides trajectories.
CONCLUSIONS
CONCLUSIONS
The most frequently observed trajectories across midlife were characterized by low physical activity, low HDL cholesterol, moderate LDL cholesterol, and low triglycerides. Despite the absence of an association between long-term trajectories of PA and blood lipids in this study, a large body of evidence has established the importance of clinical and public health messaging and interventions targeted at midlife women to promote regular and sustained PA during midlife to achieve other cardiovascular and metabolic benefits.
Identifiants
pubmed: 33722364
pii: S0378-5122(21)00019-0
doi: 10.1016/j.maturitas.2021.02.002
pmc: PMC7966732
mid: NIHMS1674687
pii:
doi:
Substances chimiques
Cholesterol, HDL
0
Cholesterol, LDL
0
Triglycerides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-56Subventions
Organisme : NIA NIH HHS
ID : U01 AG012554
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024131
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012505
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK079626
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024824
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012535
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012553
Pays : United States
Organisme : NINR NIH HHS
ID : U01 NR004061
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012539
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK092924
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012546
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012495
Pays : United States
Organisme : NIA NIH HHS
ID : U19 AG063720
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK116684
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG012531
Pays : United States
Organisme : NICHD NIH HHS
ID : K99 HD100585
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
Circulation. 2019 Jun 18;139(25):e1082-e1143
pubmed: 30586774
Obes Rev. 2016 Dec;17(12):1226-1244
pubmed: 27743411
J Gerontol A Biol Sci Med Sci. 2002 Feb;57(2):B54-60
pubmed: 11818424
Am J Ind Med. 1995 Dec;28(6):783-97
pubmed: 8588564
J Am Coll Cardiol. 2013 Jul 16;62(3):191-200
pubmed: 23684687
N Engl J Med. 1989 Sep 7;321(10):641-6
pubmed: 2488072
Curr Hypertens Rep. 2013 Dec;15(6):659-68
pubmed: 24052212
Heart. 2020 Apr;106(7):499-505
pubmed: 32098806
Atherosclerosis. 2007 Nov;195(1):e191-6
pubmed: 17482196
Semin Reprod Med. 2010 Sep;28(5):426-34
pubmed: 20865657
Eur J Epidemiol. 2015 Jul;30(7):529-42
pubmed: 26092138
N Engl J Med. 2002 Nov 7;347(19):1483-92
pubmed: 12421890
Dis Markers. 2013;35(2):85-96
pubmed: 24167352
J Womens Health (Larchmt). 2010 Oct;19(10):1815-22
pubmed: 20929415
Lancet. 2004 Jan 10;363(9403):157-63
pubmed: 14726171
J Clin Lipidol. 2016 Jul-Aug;10(4):962-969
pubmed: 27578129
Menopause. 2012 Jul;19(7):760-7
pubmed: 22395454
Prev Med. 1999 Mar;28(3):313-23
pubmed: 10072751
Curr Opin Lipidol. 2017 Aug;28(4):328-336
pubmed: 28459707
Res Q Exerc Sport. 2018 Jun;89(2):173-182
pubmed: 29578858
J Clin Lipidol. 2009 Oct;3(5):345-50
pubmed: 21291833
Prev Cardiol. 2003 Winter;6(1):22-8
pubmed: 12624558
Stroke. 2015 Jun;46(6):1735-9
pubmed: 25882053
Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):967-72
pubmed: 23021775
JAMA. 2007 Jul 18;298(3):309-16
pubmed: 17635891
J Am Heart Assoc. 2016 Sep 14;5(9):
pubmed: 27628572
BMC Med. 2017 Jan 4;15(1):2
pubmed: 28049531
Lancet. 2014 Aug 16;384(9943):618-625
pubmed: 25131981
J Lipid Res. 1978 Jan;19(1):65-76
pubmed: 202660
Arch Intern Med. 1998 Aug 10-24;158(15):1633-40
pubmed: 9701097
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Med Sci Sports Exerc. 2000 Jul;32(7):1327-38
pubmed: 10912901
Circulation. 2007 Nov 6;116(19):2110-8
pubmed: 17967770
Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2189-98
pubmed: 10479662
Menopause. 2011 Apr;18(4):376-84
pubmed: 21107300
J Phys Act Health. 2019 May 1;16(5):348-354
pubmed: 30991881
Menopause. 2014 Dec;21(12):1269-76
pubmed: 24937024
J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73
pubmed: 20082925
Eur J Cardiovasc Prev Rehabil. 2008 Jun;15(3):247-57
pubmed: 18525378
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2236-2244
pubmed: 30026268
Stat Methods Med Res. 2018 Jul;27(7):2015-2023
pubmed: 29846144
Clin Res Cardiol. 2017 Apr;106(4):237-248
pubmed: 28124099
Circulation. 2011 Aug 16;124(7):789-95
pubmed: 21810663
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
pubmed: 742764
J Am Diet Assoc. 1992 Jun;92(6):686-93
pubmed: 1607564
Prev Med. 1990 Mar;19(2):147-57
pubmed: 2359739